Athena Countouriotis Insider Trading $TPTX Turning Point Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Athena Countouriotis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).
Athena Countouriotis in Turning Point Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Athena Countouriotis: President & CEO
Holdings: 68,195 shares
Latest Transaction: Feb 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Athena Countouriotis in Turning Point Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | M | 3.20 | 8,942 | 28,614 | 173,389 | |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | M | 3.20 | 25,392 | 81,254 | 182,331 | |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | M | 3.20 | 7,666 | 24,531 | 67,575 | |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | M | 3.20 | 18,000 | 57,600 | 207,723 | |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 138.55 | 3,052 | 422,855 | 50,195 | 53.2 K to 50.2 K (-5.73 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 137.66 | 1,571 | 216,264 | 53,247 | 54.8 K to 53.2 K (-2.87 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 136.45 | 4,319 | 589,328 | 54,818 | 59.1 K to 54.8 K (-7.30 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | M | 3.20 | 8,942 | 28,614 | 59,137 | 50.2 K to 59.1 K (+17.81 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 138.19 | 433 | 59,836 | 50,195 | 50.6 K to 50.2 K (-0.86 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 137.46 | 2,081 | 286,054 | 50,628 | 52.7 K to 50.6 K (-3.95 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 136.42 | 16,626 | 2,268,119 | 52,709 | 69.3 K to 52.7 K (-23.98 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 135.72 | 5,227 | 709,408 | 69,335 | 74.6 K to 69.3 K (-7.01 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 134.34 | 1,025 | 137,699 | 74,562 | 75.6 K to 74.6 K (-1.36 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | M | 3.20 | 25,392 | 81,254 | 75,587 | 50.2 K to 75.6 K (+50.59 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 140.24 | 1,104 | 154,825 | 50,195 | 51.3 K to 50.2 K (-2.15 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 139.69 | 13,290 | 1,856,480 | 51,299 | 64.6 K to 51.3 K (-20.58 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 138.66 | 4,969 | 689,002 | 64,589 | 69.6 K to 64.6 K (-7.14 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 137.58 | 103 | 14,171 | 69,558 | 69.7 K to 69.6 K (-0.15 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Sell | S | 136.29 | 6,200 | 844,998 | 69,661 | 75.9 K to 69.7 K (-8.17 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | M | 3.20 | 7,666 | 24,531 | 75,861 | 68.2 K to 75.9 K (+11.24 %) |
| Feb 11 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | M | 3.20 | 18,000 | 57,600 | 68,195 | 50.2 K to 68.2 K (+35.86 %) |
| Feb 10 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | A | 140.01 | 101,775 | 14,249,518 | 101,775 | |
| Feb 10 2021 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Grant | A | 0.00 | 22,617 | 0 | 50,195 | 27.6 K to 50.2 K (+82.01 %) |
| May 26 2020 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | P | 60.00 | 4,166 | 249,960 | 26,872 | 22.7 K to 26.9 K (+18.35 %) |
| Jan 08 2020 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Option Exercise | A | 63.33 | 325,000 | 20,582,250 | 325,000 | |
| Jan 08 2020 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Grant | A | 31.13 | 706 | 21,976 | 22,706 | 22 K to 22.7 K (+3.21 %) |
| Sep 11 2019 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | P | 45.00 | 10,000 | 450,000 | 22,000 | 12 K to 22 K (+83.33 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Countouriotis Athena | President & CEO | Buy | P | 18.00 | 12,000 | 216,000 | 12,000 | 0 to 12 K |
Page: 1